FIELD: medicine; pharmacology.
SUBSTANCE: application of hederagenine 3-O- α -L-rhamnopyranosyle(1→2)-[b-D-glucopyranosyle(1→4)]-α -L-arabinopyranosyde or containing extract Pulsatillae radix and application of water-soluble fraction of Pulsatillae radix extract containing hederagenine 3-O- α -L- rhamnopyranosyle(1→2)-[b-D- glucopyranosyle(1→4)]- α -L-arabinopyranosyde as a therapeutic agent for solid tumours.
EFFECT: large-scale inhibition of tumour increase on solid tumours cells; relatively low toxicity; decrease of side effects of well-known antitumour agents.
8 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF ANTITUMOR ACTIVITY (VERSIONS) AND METHOD FOR ITS OBTAINING (VERSIONS) | 1999 |
|
RU2201759C2 |
| IMMUNE ENHANCING AGENT FOR TREATING A MALIGNANT NEOPLASM WITH USING AN ALLERGIN-1 ANTAGONIST | 2016 |
|
RU2734777C2 |
| L-α-AMINO -γ-LITHIUM METHYLMERCAPTOBUTYRATE HAVING ANTITUMOR AND ANTIULCER ACTIVITY | 1994 |
|
RU2114853C1 |
| N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
| PHARMACEUTICAL COMPOSITION BASED ON 6-[(4-METHYL-1-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H,10 H)-DIONE AS ANTI-TUMOUR MEDICATION | 2013 |
|
RU2523387C1 |
| ANTIBODY SPECIFICALLY BINDING TO ErbB3, AND USE THEREOF | 2016 |
|
RU2707121C2 |
| DERIVATIVES OF GLYCOSIDES OF INDOLO[2,3-A]-PYRROLO[3,4-C]CARBAZOL-5,7-DIONES ELICITING CYTOTOXIC AND ANTITUMOR ACTIVITY | 2003 |
|
RU2255089C1 |
| N-NITROSO-N-[(2-CHLOROETHYL)CARBAMOYL]-L- ORNITHINE | 2012 |
|
RU2503657C1 |
| MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
| COMBINED METHODS OF THERAPY FOR TREATMENT OF CANCEROUS TUMORS | 2017 |
|
RU2747258C2 |
